Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612150
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of TML-6 in Participants With Early Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Merry Life Biomedical Co., Ltd. 210
Testing effectiveness (Phase 2)Study completedNCT05104463
What this trial is testing

CST-2032 and CST-107 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's or Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentDementia
CuraSen Therapeutics, Inc. 64
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Not applicableLooking for participantsNCT05997030
What this trial is testing

Low-Intensity Focused Ultrasound (LIFU) Neuromodulation

Who this might be right for
Alzheimer Disease
Ali Rezai 15
Testing effectiveness (Phase 2)Looking for participantsNCT07027072
What this trial is testing

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd 114
Not applicableEnrolling By InvitationNCT06761066
What this trial is testing

Efficacy and Safety of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Who this might be right for
Alzheimer Disease
NVP Healthcare 60
Testing effectiveness (Phase 2)Study completedNCT04602624
What this trial is testing

Evaluate the Safety and Tolerability of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Dementia
Supernus Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Looking for participantsNCT06850597
What this trial is testing

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Who this might be right for
MCIMCI-AD, Early Stage Alzheimer's DiseaseAlzheimer's Disease
Medical University of Lodz 30
Not applicableLooking for participantsNCT07786116
What this trial is testing

The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions

Who this might be right for
PARKINSON DISEASE (Disorder)ParkinsonParkinson Disease+19 more
University of Cambridge 215
Not applicableUnknownNCT06400368
What this trial is testing

Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
NeuroVision Imaging 200
Not applicableLooking for participantsNCT04124029
What this trial is testing

Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

Who this might be right for
Mild Traumatic Brain InjuryModerate Traumatic Brain InjuryMild Cognitive Impairment
VA Office of Research and Development 800
Testing effectiveness (Phase 2)Looking for participantsNCT07553338
What this trial is testing

Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseAlzheimer's Disease
Weill Medical College of Cornell University 20
Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Not applicableLooking for participantsNCT07224607
What this trial is testing

Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study

Who this might be right for
Alzheimer's Disease
Cedars-Sinai Medical Center 45
Early research (Phase 1)Study completedNCT06114745
What this trial is testing

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Atridia Pty Ltd. 2
Large-scale testing (Phase 3)Ended earlyNCT02284906
What this trial is testing

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 40
Early research (Phase 1)Ended earlyNCT06247345
What this trial is testing

A Phase Ia/Ib, First-in-human (FIH) Study for Safety, Tolerability, Pharmacokinetics (PK), and Clinical Activity Evaluation of ADEL-Y01

Who this might be right for
Alzheimer Disease
Alzheimer's Disease Expert Lab (ADEL), Inc. 42
Early research (Phase 1)Study completedNCT04931459
What this trial is testing

Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Who this might be right for
Alzheimer Disease
Acumen Pharmaceuticals 65
Not applicableUnknownNCT06508268
What this trial is testing

Language, Speech and Motor Function in MCI Due to AD and Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseMCI Due to ADDementia Alzheimers
Hanze University of Applied Sciences Groningen 208
Not applicableStudy completedNCT05544201
What this trial is testing

Transcranial Alternating Current Stimulation (TACS) for Sleep Disturbances in Neurocognitive Disorders Due to Alzheimer's Disease

Who this might be right for
Brain StimulationAlzheimer DiseasetACS+3 more
Chinese University of Hong Kong 99
Next Page